EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

MiRNA-146a—A Key Player in Immunity and Diseases

Irina Gilyazova iD, Dilara Asadullina iD, Evelina Kagirova, Ruhi Sikka, Artur Mustafin, Elizaveta Ivanova, Ksenia Bakhtiyarova, Gulshat Gilyazova iD, Saurabh Gupta, Elza Khusnutdinova iD, Himanshu Gupta iD, Valentin Pavlov

International Journal of Molecular Sciences · 14.08.2023 · 24 (16) · 12767

DOI: 10.3390/ijms241612767 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.08.2023. Verfasst von Irina Gilyazova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Subdivision of the Ufa Federal Research Centre of the Russian Academy of Sciences, Institute of Biochemistry and Genetics, 450054 Ufa, Russia. Hauptthemen laut MEDLINE: Autoimmune Diseases, MicroRNAs. Die Arbeit wurde bisher 115-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation, Bashkir State Medical University Strategic Academic Leadership Program, Science and Engineering Research Board (SERB), India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

miRNA-146a, a single-stranded, non-coding RNA molecule, has emerged as a valuable diagnostic and prognostic biomarker for numerous pathological conditions. Its primary function lies in regulating inflammatory processes, haemopoiesis, allergic responses, and other key aspects of the innate immune system. Several studies have indicated that polymorphisms in miRNA-146a can influence the pathogenesis of various human diseases, including autoimmune disorders and cancer. One of the key mechanisms by which miRNA-146a exerts its effects is by controlling the expression of certain proteins involved in critical pathways. It can modulate the activity of interleukin-1 receptor-associated kinase, IRAK1, IRAK2 adaptor proteins, and tumour necrosis factor (TNF) targeting protein receptor 6, which is a regulator of the TNF signalling pathway. In addition, miRNA-146a affects gene expression through multiple signalling pathways, such as TNF, NF-κB and MEK-1/2, and JNK-1/2. Studies have been carried out to determine the effect of miRNA-146a on cancer pathogenesis, revealing its involvement in the synthesis of stem cells, which contributes to tumourigenesis. In this review, we focus on recent discoveries that highlight the significant role played by miRNA-146a in regulating various defence mechanisms and oncogenesis. The aim of this review article is to systematically examine miRNA-146a’s impact on the control of signalling pathways involved in oncopathology, immune system development, and the corresponding response to therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesMicroRNAsHumansCarcinogenesisCell Transformation, NeoplasticAdaptor Proteins, Signal Transducing

Stichwörter der Autor:innen

cancerimmunitymiRNAmiRNA-146a

Substanzen

Adaptor Proteins, Signal TransducingMicroRNAs

Autor:innen und Institutionen

  • Subdivision of the Ufa Federal Research Centre of the Russian Academy of Sciences, Institute of Biochemistry and Genetics, 450054 Ufa, Russia.
  • Institute of Urology and Clinical Oncology, Department of Medical Genetics and Fundamental Medicine, Bashkir State Medical University, 450008 Ufa, Russia.
  • Department of Biotechnology, Institute of Applied Sciences and Humanities, GLA University, Mathura 281406, India.

ORCID-Profile: Irina Gilyazova, Dilara Asadullina, Gulshat Gilyazova, Elza Khusnutdinova, Himanshu Gupta

Förderung

  • Ministry of Science and Higher Education of the Russian Federation
  • Bashkir State Medical University Strategic Academic Leadership Program
  • Science and Engineering Research Board (SERB), India
  • Russian Science Foundation

Zitieren

APA

Gilyazova, I., Asadullina, D., Kagirova, E., Sikka, R., Mustafin, A., Ivanova, E., Bakhtiyarova, K., Gilyazova, G., Gupta, S., Khusnutdinova, E., Gupta, H., & Pavlov, V. (2023). MiRNA-146a—A Key Player in Immunity and Diseases. International Journal of Molecular Sciences, 24(16), 12767. https://doi.org/10.3390/ijms241612767

Vancouver

Gilyazova I, Asadullina D, Kagirova E, Sikka R, Mustafin A, Ivanova E, et al. MiRNA-146a—A Key Player in Immunity and Diseases. International Journal of Molecular Sciences. 2023;24(16):12767. doi:10.3390/ijms241612767

BibTeX
@article{Gilyazova2023,
  author = {Gilyazova, Irina and Asadullina, Dilara and Kagirova, Evelina and Sikka, Ruhi and Mustafin, Artur and Ivanova, Elizaveta and Bakhtiyarova, Ksenia and Gilyazova, Gulshat and Gupta, Saurabh and Khusnutdinova, Elza and Gupta, Himanshu and Pavlov, Valentin},
  title = {MiRNA-146a—A Key Player in Immunity and Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {16},
  pages = {12767},
  doi = {10.3390/ijms241612767}
}
Kostenlos starten →